- Home
- EPR vs PCVX Comparison
EPR vs PCVX Comparison
Compare EPR & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EPR | PCVX |
|---|---|---|
| Founded | 1997 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 6.0B |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EPR | PCVX |
|---|---|---|
| Price | $51.90 | $46.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 7 |
| Target Price | $57.06 | ★ $101.67 |
| AVG Volume (30 Days) | 601.2K | ★ 1.5M |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | ★ 6.86% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.29 | N/A |
| Revenue | ★ $707,150,000.00 | N/A |
| Revenue This Year | $5.11 | N/A |
| Revenue Next Year | $2.70 | N/A |
| P/E Ratio | $22.60 | ★ N/A |
| Revenue Growth | ★ 3.73 | N/A |
| 52 Week Low | $41.75 | $27.66 |
| 52 Week High | $61.24 | $94.60 |
Technical Indicators
Market Signals| Indicator | EPR | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 51.97 |
| Support Level | $51.76 | $43.78 |
| Resistance Level | $52.95 | $48.11 |
| Average True Range (ATR) | 0.91 | 1.99 |
| MACD | 0.17 | -0.49 |
| Stochastic Oscillator | 49.24 | 42.99 |
Price Performance
Historical ComparisonAbout EPR EPR Properties
EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.